Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarrazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report-Reference-Cited by-同舟云学术

Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarrazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report

Published:1990-02 Issue:2 Volume:18 Page:321-324
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Levin Victor A.,Silver Pamela,Hannigan John,Wara William M.,Gutin Philip H.,Davis Richard L.,Wilson Charles B.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference15 articles.

1. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas;Chang;Cancer,1983

2. Regression models and life tables;Cox;J. Royal Stat. Soc.,1972

3. Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma—final evaluation;European Organization on Research And Treatment of Cancer;Eur. J. Cancer,1978

4. Randomized comparisons of radiotherapy and CCNU versus radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery. A Southwest Oncology Group report;Eyre;J. Neuro-Oncol.,1983

5. Comparison of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma;Green;Cancer Treat. Rep.,1983

Cited by 344 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update for astrocytomas: medical and surgical management considerations;Exploration of Neuroscience;2023-02-23

2. CAN HYPOFRACTIONATED REIRRADIATION PLUS TEMOZOLAMIDE BE A WISE CHOICE FOR RECURRENT HIGH AND LOW GRADE BRAIN TUMORS?;Journal of Radiation Research and Applied Sciences;2021-01-01

3. Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2020-11

4. Carmustine as a Supplementary Therapeutic Option for Glioblastoma: A Systematic Review and Meta-Analysis;Frontiers in Neurology;2020-09-17

5. Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large series;Journal of Neurosurgery;2020-09